Mechanisms for cross-neutralisation of diverse bat sarbecoviruses
Upadhyay, A., Seow, J., Alguel, Y., Newman, J., Thakur, N., Tam, J.C.H., Nans, A., Bailey, D., Cherepanov, P., Doores, K.J.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
wwPDB Validation 3D Report Full Report
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| VA14_26 Antibody Light Chain | 213 | Homo sapiens | Mutation(s): 0  | ![]() | |
Entity ID: 2 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| VA14_26 antibody Heavy Chain | 238 | Homo sapiens | Mutation(s): 0  | ![]() | |
Entity ID: 3 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Spike glycoprotein | 1,239 | Bat SARS-like coronavirus WIV1 | Mutation(s): 3  | ![]() | |
UniProt | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | U5WI05 | ||||
Glycosylation | |||||
| Glycosylation Sites: 8 | |||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 1 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| NAG Download:Ideal Coordinates CCD File | D [auth C] E [auth C] F [auth C] G [auth C] H [auth C] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N | |||
| Task | Software Package | Version |
|---|---|---|
| RECONSTRUCTION | cryoSPARC | 4.6.2 |
| MODEL REFINEMENT | PHENIX | 1.21.2_5419 |
| Funding Organization | Location | Grant Number |
|---|---|---|
| Wellcome Trust | United Kingdom | CC2058 |
| Medical Research Council (MRC, United Kingdom) | United Kingdom | CC2058 |
| Cancer Research UK | United Kingdom | CC2058 |